Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 7/20 | 0.71 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.67 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.67 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.55 |
| ▸ | TEAD4 | Q15561 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | DHODH | Q02127 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31207342 | 1.00 | MPO (0.71) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| SCHEMBL23691075 | 0.83 | MPO (0.76) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| SCHEMBL21068140 | 0.83 | MPO (0.61) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| SCHEMBL31207343 | 0.83 | MPO (0.61) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| SCHEMBL21068139 | 0.83 | MPO (0.61) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| SCHEMBL1688342 | 0.82 | MPO (1.00) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| Flufenamic Acid SCHEMBL17497 | 0.81 | RXFP1 (0.75) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| Flufenamic Acid SCHEMBL29356958 | 0.81 | RXFP1 (0.75) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| Flufenamic Acid SCHEMBL9845499 | 0.80 | RXFP1 (0.73) | MPOAKR1C3AKR1C2RXFP1TEAD4 | |
| Flufenamic Acid SCHEMBL11524554 | 0.80 | RXFP1 (0.73) | MPOAKR1C3AKR1C2RXFP1TEAD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3732162-B1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INST PASTEUR DE MONTEVIDEO (UY) | 2024-03-06 | — | — | EP | disclosed |
| US-20210107860-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2021-04-15 | — | — | US | disclosed |
| US-20210107860-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2021-04-15 | — | — | US | disclosed |
| US-10906864-B2 | Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation related conditions | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2021-02-02 | — | — | US | disclosed |
| US-10906864-B2 | Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation related conditions | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2021-02-02 | — | — | US | disclosed |
| EP-3732162-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | Institut Pasteur De Montevideo (UY) | 2020-11-04 | — | — | EP | disclosed |
| CN-111655665-A | Nitro-alkene non-steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation-related disorders | 蒙得维的亚巴斯德研究所 | 2020-09-11 | — | — | CN | disclosed |
| US-10428008-B2 | Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation related conditions | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2019-10-01 | — | — | US | disclosed |
| US-10428008-B2 | Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation related conditions | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2019-10-01 | — | — | US | disclosed |
| US-20190194121-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2019-06-27 | — | — | US | disclosed |
| US-20190194121-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | INSTITUT PASTEUR DE MONTEVIDEO (UY) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194121-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | PTGES, PTGS1, PTGIS | MPO 32/4885AKR1C3 659/4885AKR1C2 675/4885 |
| US-10428008-B2 | Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation related conditions | PTGES, PTGS1, PTGIS | MPO 32/4885AKR1C3 659/4885AKR1C2 675/4885 |
| US-20210107860-A1 | NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS | PTGES, PTGS1, PTGIS | MPO 32/4885AKR1C3 659/4885AKR1C2 675/4885 |
| US-10906864-B2 | Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation related conditions | PTGES, PTGS1, PTGIS | MPO 32/4885AKR1C3 659/4885AKR1C2 675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.